Cargando…
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study
PURPOSE: People living with cancer and haematological malignancies are at an increased risk of hospitalisation and death following infection with acute respiratory syndrome coronavirus 2. Coronavirus third dose vaccine boosters are proposed to boost waning immune responses in immunocompromised indiv...
Ejemplares similares
-
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study
por: Lee, Lennard Y W, et al.
Publicado: (2022) -
A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)
por: Starkey, Thomas, et al.
Publicado: (2023) -
Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review
por: Al Hajji, Youssra, et al.
Publicado: (2022) -
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research
por: Fittall, Matthew, et al.
Publicado: (2023) -
As COVID-19 cases surge despite mass vaccination, it’s time to focus on the vulnerable
por: Little, Martin, et al.
Publicado: (2021)